• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zai Lab Announces Participation in Investor Conferences in March 2025

By: Zai Lab Limited via Business Wire
March 03, 2025 at 07:30 AM EST

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in March 2025:

Leerink Partners 2025 Global Healthcare Conference

Fireside Chat: Monday, March 10, 2025, 9:20 a.m. EST

Location: Miami, FL

Jefferies Biotech on the Beach Summit

Time: Tuesday, March 11, 2025

Location: Miami, FL

A live webcast of the fireside chat will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations and archived replay will be available for up to 90 days following the completion of the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.

For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.X.com/ZaiLab_Global.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250303343037/en/

Contacts

For more information, please contact:

Investor Relations:

Christine Chiou / Lina Zhang

+1 (917) 886-6929 / +86 136 8257 6943

christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com

Media:

Shaun Maccoun / Xiaoyu Chen

+1 (857) 270-8854 / +86 185 0015 5011

shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com

More News

View More
Palantir’s New Healthcare Deal Boosts AI and Data Reach
Today 19:16 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers ONMD PLTR
GM's Billion-Dollar Bruise: GM's Strategic Pivot Makes It a Buy
Today 18:09 EDT
Via MarketBeat
Topics Electric Vehicles
Tickers GM
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Today 16:15 EDT
Via MarketBeat
Topics World Trade
Tickers LLY NVO SEPN
ASML Can Hit New Highs, But It Won’t Be Easy: Here’s Why
Today 16:03 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers ASML
Vertiv Stock Surges on Strategic CFO Hire and AI Momentum
Today 15:41 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers NVDA VRT WAB
Recent Quotes
View More
Symbol Price Change (%)
GOOG  251.71
+5.52 (2.24%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap